Research Funding

Alkermes Pathways Research Awards

With millions of people impacted by central nervous system disorders, more research is urgently needed to bring relief to those who are suffering. The ALKERMES PATHWAYS RESEARCH AWARDS® program furthers our commitment to serving the needs of patients and is designed to support the next generation of researchers who are working on the front-lines to advance our understanding and awareness of central nervous system disorders.

In its second year (2019), the ALKERMES PATHWAYS RESEARCH AWARDS® program will support projects focused on substance use disorders (SUDs) and schizophrenia.

Open to early career investigators committed to advancing research in SUDs and schizophrenia, the annual Pathways program provides funding for up to 8 research projects with an individual grant amount of up to $100,000 per project. Alkermes has reserved 4 awards for the SUDs program and 4 for the schizophrenia program.

2019 Areas of Interest
Substance Use Disorder (SUD) Schizophrenia
• Research on SUD treatment, management, and prevention • Research on assessment methods addressing barriers to optimal outcomes for persons with schizophrenia
• Research on SUD and its complications in special populations • Research on patient-centered outcomes
• Preclinical, clinical, translational, and epidemiological research related to SUD • Preclinical and translational research related to pathophysiology of schizophrenia or its treatment
• Short-term and long-term economic and clinical outcomes using real-world data in SUDs • Health economic outcomes research related to schizophrenia


This grant is for investigators who are in the early stages of their career; specifically, they may be the recipient of a career development (K) award or other mentored research grant, but not a funded R01 grant or equivalent at the time of application.

Researchers with an academic position above assistant professor are not eligible.

ALKERMES PATHWAYS RESEARCH AWARDS® program grants will be awarded to researchers who have demonstrated a commitment to SUD or schizophrenia research. Eligible applicants must meet the following criteria:

  • Have an MD, PhD, or equivalent
  • Affiliated with a medical or research center within the United States at the time of application
  • Within 5 years of initial academic appointment (e.g., assistant professor) or current postdoctoral fellow
  • Research focuses primarily on furthering knowledge of SUDs or schizophrenia
  • Have a research mentor with extensive experience in the field of SUDs or schizophrenia
  • Have not received an NIH R01 grant at the time of award
  • Able to complete the proposed research within 2 years
  • Citizen or permanent resident of the United States or hold a temporary non-immigrant visa that is valid for the duration of the 2-year grant period

Selection Criteria

All applications will be formally reviewed by an independent Review Committee comprising prominent researchers in the relevant field. The Review Committee has final responsibility for selection of Awardees.

When the Review Committee evaluates a proposal, they will consider criteria, including but not limited to:

  • Overall impact
  • Candidate
  • Mentor
  • Environment and institutional commitment to the applicant
  • Research plan

Note that applications are not required to include an Alkermes product.

Application Process

All applications, regardless of area of interest, should be submitted by email to

The following items should be included in the submission email:

  • Completed Application Form
  • Completed Budget Form
  • NIH Biosketch of applicant
  • Letter (1 page) of mentor support
  • Letter (1 page) from Division Chief or Department Head confirming academic appointment (or postdoctoral fellowship)
  • Up to 3 optional supporting documents
    Attachments may be sent as individual files or in a zip file.

The Application Form is available HERE.
The Budget Form is available HERE.
Please note, you may need to right-click and select “save target as” to download the files.

Applicants should use the information contained in the guidance document to complete their applications. The program Guidance is available HERE.

Key Dates

Application Process Open – April 1, 2019

Application Deadline – July 31, 2019 (by 11:59 pm Eastern Daylight Time)

Notification of Review Committee Decision – November 2019
Public Announcement of Awardees – Quarter 1, 2020

Further Information
If you require clarification of any information, please contact the Pathway Research Awards Program Manager by the email

Leave a Reply

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.